Tejnaksh Healthcare Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 Mar-2018 Mar-2017 Mar-2016
Growth matrix (%)        
Revenue growth 17.50 95.80 53.40 --
Op profit growth (28) 61.20 39.20 --
EBIT growth (29) 73.40 43.10 --
Net profit growth (28) 59.20 37.90 --
Profitability ratios (%)        
OPM 22 36.10 43.80 48.30
EBIT margin 22.20 36.90 41.70 44.70
Net profit margin 12.50 20.30 25 27.80
RoCE 17.70 31.60 28.50 --
RoNW 4.12 7.97 6.37 --
RoA 2.48 4.35 4.29 --
Per share ratios ()        
EPS 2.11 14.40 8.64 12
Dividend per share -- -- -- --
Cash EPS 1.41 11 6.68 10.10
Book value per share 15 45.90 36.50 56.50
Valuation ratios        
P/E 17.10 6.41 9.16 0.74
P/CEPS 25.50 8.38 11.80 0.88
P/B 2.40 2.01 2.17 0.16
EV/EBIDTA 9.69 17.40 25.30 3.68
Payout (%)        
Dividend payout -- -- -- --
Tax payout (28) (26) (33) (38)
Liquidity ratios        
Debtor days 5.45 (0.40) -- --
Inventory days 14.80 13.10 12 --
Creditor days (18) (25) (33) --
Leverage ratios        
Interest coverage (4.90) (5.70) (16) (1,754)
Net debt / equity 0.39 0.58 0.65 (0.10)
Net debt / op. profit 1.60 1.15 1.64 (0.20)
Cost breakup ()        
Material costs (7.70) (8.40) (12) (14)
Employee costs (15) (14) (12) (10)
Other costs (55) (41) (32) (27)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Revenue 16.80 14.30 7.28 4.75
yoy growth (%) 17.50 95.80 53.40 --
Raw materials (1.30) (1.20) (0.80) (0.70)
As % of sales 7.74 8.42 11.50 14.10
Employee costs (2.60) (2.10) (0.90) (0.50)
As % of sales 15.20 14.40 12.20 10.50
Other costs (9.20) (5.90) (2.40) (1.30)
As % of sales 55.10 41.10 32.50 27.10
Operating profit 3.68 5.15 3.19 2.29
OPM 22 36.10 43.80 48.30
Depreciation (0.70) (0.50) (0.30) (0.20)
Interest expense (0.80) (0.90) (0.20) --
Other income 0.70 0.58 0.19 0.03
Profit before tax 2.97 4.33 2.84 2.12
Taxes (0.80) (1.10) (0.90) (0.80)
Tax rate (28) (26) (33) (38)
Minorities and other (0.10) (0.30) (0.10) --
Adj. profit 2.09 2.90 1.82 1.32
Exceptional items -- -- -- --
Net profit 2.09 2.90 1.82 1.32
yoy growth (%) (28) 59.20 37.90 --
NPM 12.50 20.30 25 27.80
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Profit before tax 2.97 4.33 2.84 2.12
Depreciation (0.70) (0.50) (0.30) (0.20)
Tax paid (0.80) (1.10) (0.90) (0.80)
Working capital 4.95 0.50 (0.50) --
Other operating items -- -- -- --
Operating cashflow 6.44 3.25 1.06 --
Capital expenditure 15 1.09 (1.10) --
Free cash flow 21.40 4.34 -- --
Equity raised 17.20 10.90 12 --
Investments (2.60) -- 0.01 --
Debt financing/disposal 7.19 1.25 1.49 --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 43.20 16.50 13.40 --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 10.20 10.20 2.21 2.21
Preference capital -- -- -- --
Reserves 5.09 3 7.93 5.86
Net worth 15.30 13.20 10.10 8.07
Minority interest
Debt 7.19 6.33 7.64 6.39
Deferred tax liabilities (net) 0.77 0.62 0.40 0.28
Total liabilities 23.60 20.50 18.50 14.90
Fixed assets 18 17.40 15.30 13.60
Intangible assets
Investments -- -- -- 0.01
Deferred tax asset (net) 0.03 -- -- --
Net working capital 4.32 1.88 1.38 0.10
Inventories 0.64 0.83 0.72 0.30
Inventory Days 13.90 -- 18.40 15
Sundry debtors 0.53 0.19 -- --
Debtor days 11.50 -- (0.80) --
Other current assets 4.43 2.64 2.01 0.47
Sundry creditors (0.50) (0.60) (0.70) (0.50)
Creditor days 11.80 -- 18.90 26.10
Other current liabilities (0.70) (1.20) (0.60) (0.20)
Cash 1.29 1.24 1.74 1.15
Total assets 23.70 20.50 18.50 14.90
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Jun-2020 Mar-2020 Dec-2019 Sep-2019 Jun-2019
Gross Sales 1.58 3.55 4.29 4.46 4.46
Excise Duty -- -- -- -- --
Net Sales 1.58 3.55 4.29 4.46 4.46
Other Operating Income -- -- -- -- --
Other Income 0.02 0.16 0.19 0.25 0.11
Total Income 1.60 3.71 4.48 4.70 4.56
Total Expenditure ** 1.20 3.27 3.31 3.33 3.18
PBIDT 0.41 0.44 1.18 1.38 1.39
Interest 0.13 0.20 0.18 0.19 0.20
PBDT 0.27 0.24 1 1.19 1.19
Depreciation 0.17 0.17 0.17 0.16 0.16
Minority Interest Before NP -- -- -- -- --
Tax 0.03 0.06 0.19 0.20 0.25
Deferred Tax 0.03 0.06 0.05 -- 0.04
Reported Profit After Tax 0.04 (0.10) 0.59 0.86 0.75
Minority Interest After NP -- 0.01 0.01 0.04 0.01
Net Profit after Minority Interest 0.07 (0.10) 0.58 0.82 0.74
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 0.07 (0.10) 0.58 0.82 0.74
EPS (Unit Curr.) 0.04 (0.10) 0.58 0.81 0.73
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 10.20 10.20 10.20 10.20 10.20
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 25.90 12.40 27.50 30.90 31.20
PBDTM(%) 17.10 6.76 23.30 26.70 26.70
PATM(%) 2.53 (1.40) 13.80 19.30 16.80